YU201090A - Novi triazolo derivati i postupak za njihovo pravljenje - Google Patents
Novi triazolo derivati i postupak za njihovo pravljenjeInfo
- Publication number
- YU201090A YU201090A YU201090A YU201090A YU201090A YU 201090 A YU201090 A YU 201090A YU 201090 A YU201090 A YU 201090A YU 201090 A YU201090 A YU 201090A YU 201090 A YU201090 A YU 201090A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- 4alkyl
- phenyl
- group
- alkyl
- represent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Ovaj pronalazak se odnosi na nove triazolo derivate, na postupak za njihovo pravljenje, na farmaceutske preparate koji sadrže isti, na primenu pomenutih triazolo derivata za lečenje bolesti i takodje za pravljenje farmaceutskih preparata koji supodesni za lečenje pomenutih bolesti. Novi triazolo derivati opštih formula (Ia) i (Ib): Q pretstavlja vodonik ili heterocikličnu grupu koja opciono nosi jedan ili više C1-4alkil supstituenata; ili grupu formule SR1, gde R1 pretstavlja C1-4alkil pravog ili jračvastog niza ili fenil -(C1-4alkil); ili grupu formule NR2R3, gde R2 i R3 svaki pretstavljaju vodonik, C1-12alkil pravog ili račvastog niza, C2-6alkenil ili fenil-(C1-4alkil); R4 i R7 svaki pretstavljaju vodonik, C1-6alkil ili fenil-(C1-4alkil) koji opciono nose jedan ili više halogenskih supstituenata; R5 i R6 svaki pretstavljaju C1-4alkil koji je opciono supstituisan sa C1-4alkoksi karbonil grupom; heterocikličnu grupu ili fenil grupu koja opciono nosi jedan ili više halogena, hidroksilnih, cijano, nitro, di-(C1-4alkil)-amino ili C1-4alkoksi supstituenata pri čemu poslednji može nositi di -(C1-4alkil)-amino grupu; dalje jedan od R5 i R6 može pretstavljati vodonik, ili R5 i R6 zajednički pretstavljaju C4-15 alkilen ili zajedno sa susednim atomom ugljenika za koji su vezani formiraju heterocikličnu grupu koja nosi fenil-(C1-4alkil) supstituent, poseduju dragocene antianginalne i smirujuće/sedativne osobine i korisni su u terapiji.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU542989A HU205357B (en) | 1989-10-25 | 1989-10-25 | Process for producing tetrahydro-triazolo-tetrazepine derivatives and pharmaceutical compositions comprising same |
HU542789A HU206094B (en) | 1989-10-25 | 1989-10-25 | Process for producing triazolylcarboxylic acid hydrazone derivatives and pharmaceutical compositions comprising same |
Publications (1)
Publication Number | Publication Date |
---|---|
YU201090A true YU201090A (sh) | 1993-05-28 |
Family
ID=26317835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU201090A YU201090A (sh) | 1989-10-25 | 1990-10-25 | Novi triazolo derivati i postupak za njihovo pravljenje |
Country Status (10)
Country | Link |
---|---|
US (1) | US5135928A (sh) |
EP (1) | EP0425282A3 (sh) |
JP (1) | JPH03209369A (sh) |
KR (1) | KR910007894A (sh) |
BG (1) | BG51043A3 (sh) |
CA (1) | CA2028610A1 (sh) |
IL (1) | IL96127A0 (sh) |
IN (1) | IN171609B (sh) |
PL (1) | PL164805B1 (sh) |
YU (1) | YU201090A (sh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750545A (en) * | 1993-07-23 | 1998-05-12 | The Green Cross Corporation | Triazole derivative and pharmaceutical use thereof |
CA2673683C (en) | 2007-01-11 | 2014-07-29 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
US8466151B2 (en) | 2007-12-26 | 2013-06-18 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
EP2318406B1 (en) | 2008-07-17 | 2016-01-27 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
KR100986904B1 (ko) * | 2008-11-10 | 2010-10-08 | 한국항공우주산업 주식회사 | 일체형 전단 및 굽힘 시험 장치 |
WO2011120153A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2352944A (en) * | 1942-07-04 | 1944-07-04 | Gen Electric | Triazole derivatives |
GB949170A (en) * | 1960-03-15 | 1964-02-12 | France Etat | Carbamyl and thiocarbamyl substances, methods for producing same and applications thereof |
US4144233A (en) * | 1977-02-16 | 1979-03-13 | The Dow Chemical Company | Method for preparing benzo-(1,3,4)-benzotriazepines |
-
1990
- 1990-10-25 CA CA002028610A patent/CA2028610A1/en not_active Abandoned
- 1990-10-25 JP JP2286015A patent/JPH03209369A/ja active Pending
- 1990-10-25 IL IL96127A patent/IL96127A0/xx unknown
- 1990-10-25 YU YU201090A patent/YU201090A/sh unknown
- 1990-10-25 IN IN852/MAS/90A patent/IN171609B/en unknown
- 1990-10-25 EP EP19900311689 patent/EP0425282A3/en not_active Ceased
- 1990-10-25 BG BG93092A patent/BG51043A3/xx unknown
- 1990-10-25 KR KR1019900017150A patent/KR910007894A/ko not_active Application Discontinuation
- 1990-10-25 PL PL90287505A patent/PL164805B1/pl unknown
- 1990-10-25 US US07/604,486 patent/US5135928A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0425282A2 (en) | 1991-05-02 |
IL96127A0 (en) | 1991-07-18 |
JPH03209369A (ja) | 1991-09-12 |
EP0425282A3 (en) | 1991-10-16 |
PL287505A1 (en) | 1991-07-29 |
KR910007894A (ko) | 1991-05-30 |
CA2028610A1 (en) | 1991-04-26 |
PL164805B1 (pl) | 1994-10-31 |
BG51043A3 (en) | 1993-01-15 |
IN171609B (sh) | 1992-11-21 |
US5135928A (en) | 1992-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL930018I2 (nl) | (Piperidinylalkyl) chinazolinederivaten, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten. | |
DE2960820D1 (en) | Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them | |
ES478605A1 (es) | Un procedimiento para preparar derivados de flavano. | |
YU201090A (sh) | Novi triazolo derivati i postupak za njihovo pravljenje | |
DE69814473D1 (de) | Neue allythiopyridazinderivate und verfahren zu ihrer herstellung | |
ES8501772A1 (es) | Procedimiento de preparacion de nuevos derivados de la nitrosourea | |
ES8301196A1 (es) | Procedimiento de preparacion de un nuevo derivado de acido cinamoil-cinamico | |
SE8602525L (sv) | Fenantrenderivat | |
ATE18761T1 (de) | Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen. | |
EP0169009A3 (en) | Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals | |
NO852618L (no) | Aroyl-substituerte dihydro-1,4-tiaziner. | |
YU141290A (sh) | Dihidropirimidotiazin derivati | |
ATE21908T1 (de) | Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ES8200891A1 (es) | Procedimiento para preparar derivados del acido 2,7-fenan- trolina-9-carboxilico | |
ES8403471A1 (es) | Un procedimiento para preparar nuevos compuestos de cromanona. | |
YU229190A (sh) | Derivati benzofurana |